PVH
EDIT icon

Psagot Value Holdings’s Editas Medicine EDIT Stock Holding History

Psagot Value Holdings’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-500
Closed -$4K – 522
2022
Q4 		$4K Hold
500
– – ﹤0.01% 334
2022
Q3 		$6K Hold
500
– – ﹤0.01% 315
2022
Q2 		$6K Buy
+500
New +$6.7K ﹤0.01% 276

Other funds holding EDIT

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Psagot Value Holdings's EDIT Position: Q1 2023 in Review

Psagot Value Holdings sold out of Editas Medicine (EDIT) in Q1 2023, closing a stake of 500 shares — an estimated $4K sold.

Psagot Value Holdings first reported a position in EDIT in Q2 2022 and held it in 3 quarters. The position peaked at $6K in Q3 2022. 234 funds tracked by Wall St. Rank hold EDIT as of Q1 2023.

  • Psagot Value Holdings reported no remaining Editas Medicine position as of Q1 2023 after selling out during the quarter.
  • Psagot Value Holdings sold 500 Editas Medicine shares in Q1 2023, an estimated $4K.
  • Psagot Value Holdings first reported a position in Editas Medicine in Q2 2022 and held it in 3 quarters.
  • Psagot Value Holdings's Editas Medicine position peaked at $6K in Q3 2022.
  • 234 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2023.

Based on Psagot Value Holdings's 13F filing for Q1 2023, filed 20 Jun 2023.